Glass House Brands Inc

Análisis de la acción Glass House Brands Inc (GLAS)

$2.330

-0.010 (-0.43%)Al cierre

Loading chart…
Máximo
2.479
Apertura
2.370
Precio medio ponderado por volumen
2.30
Volumen
3.09M
Capitalización
—
Mínimo
2.100
Importe
7.12M
EV/EBITDA, TTM
3,721.46

Glass House Brands Inc. is a vertically integrated cannabis company. The Company, through its subsidiaries, cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and cannabis-related consumer packaged goods (CPG) to third-party retail stores in the state of California. The Company also owns and operates retail cannabis stores in the state of California. The Company operates in three reportable segments: retail, wholesale biomass and cannabis-related consumer packaged goods (CPG). The Company operates multiple greenhouse cultivation facilities located in Carpinteria and Camarillo, California, and its manufacturing production facility is located in Lompoc, California. Its portfolio of brands includes Glass House Farms, PLUS, REEFORM, Allswell, and Mama Sue Wellness. Its retail landscape consists of approximately 10 stores positioned across California, including the pottery, farmacy, and natural healing center (NHC).

Análisis de IA of Glass House Brands Inc (GLAS)

Vender

Given the current price of $3.19, the stock has seen a significant decline of 74.68% year-to-date. The RSI is extremely low at 3.639, indicating oversold conditions, but the forward P/E ratio is high at 31.4465, suggesting that the stock may be overvalued relative to its earnings potential. The gross margin has also dropped to 26.22%, down from 46.81% in the previous year, highlighting deteriorating profitability. While there is potential for recovery, the risks associated with persistent net losses and high reliance on external capital make this a sell for now.

Métricas de valoración

El PER previsto actual de Glass House Brands Inc (GLAS) es 31.45, frente a su media de 5 años de 165.51.

PER previsto

Infravalorado
Media 5A P/E
165.51
P/E actual
31.45
Sobrevalorada
278.97
Infravalorada
52.06

EV/EBITDA previsto

Muy sobrevalorado
Media 5A EV/EBITDA
-2135.07
EV/EBITDA actual
3721.46
Sobrevalorada
575.30
Infravalorada
-4845.45

Precio/ventas previsto

Muy infravalorado
Media 5A P/S
3.07
P/S actual
0.94
Sobrevalorada
3.83
Infravalorada
2.32

Cronología de eventos

2026-10-19 (ET)

09:00:00

Nasdaq Futures Rebound as Tech Stocks Recover

08:00:00

Glass House Sets FY26 Production Cost Target at $95

08:00:00

Glass House Reports Record Biomass Production of 317,000 Pounds in Q3

2026-10-14 (ET)

08:00:00

Glass House Achieves GACP Certification, Aiming for Medical Cannabis Exports

2026-09-29 (ET)

08:00:00

Glass House Brands CFO Mark Vendetti Plans Retirement

Noticias

Preguntas frecuentes sobre GLAS, respondidas por Alphio AI

Glass House Brands Inc. is a vertically integrated cannabis company. The Company, through its subsidiaries, cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and cannabis-related consumer packaged goods (CPG) to third-party retail stores in the state of California. The Company also owns and operates retail cannabis stores in the state of California. The Company operates in three reportable segments: retail, wholesale biomass and cannabis-related consumer packaged goods (CPG). The Company operates multiple greenhouse cultivation facilities located in Carpinteria and Camarillo, California, and its manufacturing production facility is located in Lompoc, California. Its portfolio of brands includes Glass House Farms, PLUS, REEFORM, Allswell, and Mama Sue Wellness. Its retail landscape consists of approximately 10 stores positioned across California, including the pottery, farmacy, and natural healing center (NHC). It operates in the Consumer Non-Cyclicals sector.

Given the current price of $3.19, the stock has seen a significant decline of 74.68% year-to-date. The RSI is extremely low at 3.639, indicating oversold conditions, but the forward P/E ratio is high at 31.4465, suggesting that the stock may be overvalued relative to its earnings potential. The gross margin has also dropped to 26.22%, down from 46.81% in the previous year, highlighting deteriorating profitability. While there is potential for recovery, the risks associated with persistent net losses and high reliance on external capital make this a sell for now.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar